Table 1. Characteristics of the studies included in the meta‐analysis.

^aDacarbazine, or paclitaxel plus carboplatin.

^bPaclitaxel plus carboplatin, paclitaxel, carboplatin, dacarbazine, or oral temozolomide.

Abbreviations: CTCAE, Common Terminology Criteria for Adverse Events; NSCLC, non‐small cell lung cancer; q, every.